CoChat

Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction

Open access
Merrill, Miranda, Sweitzer, Nancy K., Lindenfeld, JoAnn, Kao, David P. · 2019 · JACC: Heart Failure
Cited by 201

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective: Describe sex differences in outcomes and response to spironolactone in patients with heart failure with preserved ejection fraction (HFpEF). Background: HFpEF affects women more frequently than men. Sex differences in effect of mineralocorticoid antagonists have not been reported. Methods: This was an exploratory, post-hoc, non-prespecified analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT). Subjects with symptomatic HF and an LVEF ≥45% were randomized to spironolactone or placebo. Subjects enrolled from the Americas were analyzed. The primary outcome was a composite of cardiovascular (CV) death, cardiac arrest, or HF hospitalization. Secondary outcomes included all-cause, CV, and non-CV mortality, and CV, HF, and non-CV hospitalization. Sex differences in outcomes and treatment effect were determined using time-to-event analysis. Results: In total, 882/1767 (49.9%) subjects were women. Women were older with fewer comorbidities but worse patient-reported outcomes. There were no sex differences in outcomes in the placebo arm or in response to spironolactone for the primary outcome or its components. Spironolactone was associated with reduced all-cause mortality in women (HR 0.66, p=0.01), but not in men (pinteraction=0.02). Conclusions: In TOPCAT, women and men presented with different clinical profiles and similar clinical outcomes. The interaction between spironolactone and sex in TOPCAT overall and in our analysis was non-significant for the primary outcome, but there was a reduction in all-cause mortality associated with spironolactone in women with a significant interaction. Prospective evaluation is needed to determine whether spironolactone may be effective for treatment of HFpEF in women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jchf.2019.01.003

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 201

Metadata

Authors
Merrill, M., Sweitzer, N. K., Lindenfeld, J., & Kao, D. P.
Venue
JACC: Heart Failure
Publisher
Elsevier BV
Published
2019-03
Volume
7
Issue
3
Pages
228-238
ISSN
2213-1779 (ISSN-L)
OpenAlex
W2915837534
Cited by
201
References
6
FWCI
15.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.